At Altratech, our mission is to enable next generation molecular detection. We are a team of scientists and engineers (molecular biology, surface chemistry, microfluidics, and chip design) bringing together nano biotechnology, chemistry, and semiconductors to radically change the accessibility of high content genetic data. Our vision at Altratech is to create an infrastructure of technology and data to manage contagious viral diseases, important for the future of decentralised connected healthcare and wellbeing. This will facilitate continuous health monitoring, outside a clinical setting, at point-of-care, and in the home. Based on the novel Detection by Proxy concept, Altratech has developed the next generation of molecular detection. The technology enables any person, anywhere, to rapidly and accurately measure and quantify viral RNA, DNA, antigen, or antibody samples. At Altratech, we want to move the monitoring of viral contagious diseases to the point-of-care and outside of the clinical setting. We recognise the common barriers to implementing this point-of-care or home monitoring systems revolve around sample prep, reagent storage, and user expertise. However, we are committed to driving change in molecular detection, and through research and development of our KeyChain PNA probe, and novel Detection by Proxy, we can now enable this ‘Anywhere, anytime, by anyone’ technology.